XML 35 R24.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK-BASED COMPENSATION (Tables)
3 Months Ended
Mar. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
During the three months ended March 31, 2023 and 2022, Wesco granted the following stock options, restricted stock units, and performance-based awards at the following weighted-average fair values:
Three Months Ended
March 31,
2023
March 31,
2022
Stock options granted75,182 89,550 
Weighted-average fair value$76.77 $57.26 
Restricted stock units granted170,569 224,946 
Weighted-average fair value$171.03 $122.11 
Performance-based awards granted(1)
208,371 83,991 
Weighted-average fair value(1)
$85.94 $122.09 
(1)    As described further below, the three months ended March 31, 2023 includes performance-based awards granted in February 2020 for which actual achievement levels were certified in February 2023.
Share-based Payment Arrangement, Option and Stock Appreciation Rights, Activity [Table Text Block]
The following table sets forth a summary of stock-settled stock appreciation rights and related information for the three months ended March 31, 2023:
AwardsWeighted-
Average
Exercise
Price
Weighted-
Average
Remaining
Contractual Term (In years)
Aggregate
Intrinsic
Value
(In millions)
Outstanding at December 31, 2022
1,248,115 $62.02   
     Granted— —   
     Exercised(339,649)68.51  
     Forfeited(638)72.15   
Outstanding at March 31, 2023
907,828 $59.59 5.6$86.2 
Exercisable at March 31, 2023
865,198 $58.72 5.5$82.9 
For the three months ended March 31, 2023, the aggregate intrinsic value of stock-settled stock appreciation rights exercised during such period was $31.6 million.
Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]
The following table sets forth a summary of restricted stock units and related information for the three months ended March 31, 2023:
AwardsWeighted-
Average
Fair
Value
Unvested at December 31, 2022
774,233 $73.79 
     Granted170,569 171.03 
     Vested(323,156)72.05 
     Forfeited(184)102.64 
Unvested at March 31, 2023
621,462 $101.38 
Schedule of Nonvested Performance-based Units Activity [Table Text Block]
The following table sets forth a summary of performance-based awards and related information for the three months ended March 31, 2023:
AwardsWeighted-
Average
Fair
Value
Unvested at December 31, 2022
335,329 $75.26 
     Granted(1)
208,371 85.94 
     Vested(289,394)48.32 
     Forfeited— — 
Unvested at March 31, 2023
254,306 $114.66 
(1)    Includes 63,098 performance-based awards granted in February 2023 with a fair value of $171.96 and three-year performance period ending December 31, 2025, and 144,697 performance-based awards granted in February 2020 with a fair value of $48.32 and three-year performance period ended December 31, 2022 for which actual achievement levels were certified in February 2023.
Share-Based Payment Arrangement, Option, Activity
The following table sets forth a summary of stock options and related information for the three months ended March 31, 2023:
AwardsWeighted-
Average
Exercise
Price
Weighted-
Average
Remaining
Contractual Term (In years)
Aggregate
Intrinsic
Value
(In millions)
Outstanding at December 31, 2022
87,347 $121.55   
     Granted75,182 170.04   
     Exercised(1,279)122.09  
     Forfeited— —   
Outstanding at March 31, 2023
161,250 $144.15 9.4$2.9 
Exercisable at March 31, 2023
27,329 $122.09 8.9$0.9 
For the three months ended March 31, 2023, the aggregate intrinsic value of stock options exercised during such period was not material.
Stock Appreciation Rights (SARs) [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
The fair values of stock options, as disclosed in the table above, were estimated using the following weighted-average assumptions in the respective periods:
Three Months Ended
March 31,
2023
March 31,
2022
Risk free interest rate4.1 %1.9 %
Expected life (in years)57
Expected volatility50 %43 %
Expected dividend yield0.88 %n/a